Innovative medicines can provide great benefits to patients. But often are accompanied by high prices. My ideas how to deal with this from a societal perspective are written down in several interviews and opinion papers. Below the links to some of them.

Interview with Dutch Cancer Society about my research program (in Dutch)

Opinion paper in Medisch Contact (in Dutch)

When the COVID-19 pandemic started, I have slowed down my own research program to put effort in the evaluation of the safety of medicines that were prescribed off-label for COVID-19

Timely research project on side effects of chloroquine during COVID-19 pandemic (in Dutch)